Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Bernemann

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
BJU International|January 24, 2018
Performance comparison of two androgen receptor splice variant 7 (AR-V7) detection methodsChristof Bernemann, Julie Steinestel, Verena Humberg, et al.
Cancer Treatment and Research Communications|November 3, 2020
Detection of AR-V7 in primary prostate cancerAdam Kaczorowski, Xin Chen, Glen Kristiansen, et al.
European Urology|July 30, 2016
Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate CancerChristof Bernemann, Thomas J Schnoeller, Manuel Luedeke, et al.
Cancer Cell International|August 27, 2025
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utilityNeele Wüstmann, Verena Humberg, Julia Vieler, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 2, 2025
Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancerNeele Wüstmann, Julissa Reimann, Julia Vieler, et al.
Oncology Letters|November 29, 2023
Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancerMahmoud Abbas, Barbara Heitplatz, Christof Bernemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate CancerChristof Bernemann, Verena Humberg, Barbara Thielen, et al.
Oncotarget|November 21, 2017
Comparison of isolation platforms for detection of circulating renal cell carcinoma cellsYvonne Maertens, Verena Humberg, Franziska Erlmeier, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Distinct developmental ground states of epiblast stem cell lines determine different pluripotency featuresChristof Bernemann, Boris Greber, Kinarm Ko, et al.
Theranostics|July 21, 2020
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
BJU International|January 24, 2018
Performance comparison of two androgen receptor splice variant 7 (AR-V7) detection methodsChristof Bernemann, Julie Steinestel, Verena Humberg, et al.
Cancer Treatment and Research Communications|November 3, 2020
Detection of AR-V7 in primary prostate cancerAdam Kaczorowski, Xin Chen, Glen Kristiansen, et al.
European Urology|July 30, 2016
Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate CancerChristof Bernemann, Thomas J Schnoeller, Manuel Luedeke, et al.
Cancer Cell International|August 27, 2025
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utilityNeele Wüstmann, Verena Humberg, Julia Vieler, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 2, 2025
Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancerNeele Wüstmann, Julissa Reimann, Julia Vieler, et al.
Oncology Letters|November 29, 2023
Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancerMahmoud Abbas, Barbara Heitplatz, Christof Bernemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate CancerChristof Bernemann, Verena Humberg, Barbara Thielen, et al.
Oncotarget|November 21, 2017
Comparison of isolation platforms for detection of circulating renal cell carcinoma cellsYvonne Maertens, Verena Humberg, Franziska Erlmeier, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Distinct developmental ground states of epiblast stem cell lines determine different pluripotency featuresChristof Bernemann, Boris Greber, Kinarm Ko, et al.
Theranostics|July 21, 2020
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Pageof 5